(NASDAQ: INGN) Inogen's forecast annual revenue growth rate of 5.11% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.56%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.43%.
Inogen's revenue in 2025 is $335,705,000.On average, 3 Wall Street analysts forecast INGN's revenue for 2025 to be $9,359,782,300, with the lowest INGN revenue forecast at $9,346,888,942, and the highest INGN revenue forecast at $9,375,540,850. On average, 3 Wall Street analysts forecast INGN's revenue for 2026 to be $9,870,131,138, with the lowest INGN revenue forecast at $9,757,566,283, and the highest INGN revenue forecast at $9,967,945,567.
In 2027, INGN is forecast to generate $10,281,126,834 in revenue, with the lowest revenue forecast at $10,091,838,538 and the highest revenue forecast at $10,470,415,130.